3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
5
Breast Neoplasms
3
Colorectal Neoplasms
2
Breast Carcinoma In Situ
2
Squamous Cell Carcinoma of Head and Neck
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Polyps
1
Patient Satisfaction
1
Ovarian Neoplasms
1
Neuromuscular Junction Diseases
1
Nervous System Diseases
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Myasthenia Gravis
1
Muscle Weakness
1
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Immune System Diseases
1
Hodgkin Disease
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Head and Neck Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Chronic Pain
1
Cervical Cancer Screening
1
Cancer Pain
1
Autoimmune Diseases of the Nervous System
1
Autoimmune Diseases
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
telitacicept
1
nicotinamide-beta-riboside
1
Testosterone
1
Telemedicine
1
Exercise Movement Techniques
1
Creatine
1
Autogenic Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Muscle Weakness
×
Telemedicine
×
Clear all
NCT05917184
2023-06-23
ADAPT-teleMG
Yale University
Completed
52 enrolled